615 |
Tim-3 as an Immune Therapy Target, Mechanism and Action, and Prognostic Values with its Ligands in Patient StratificationSession Category: Immunology -Immune Checkpoints |
|
615A |
HuGEMMTM Modelling Toxicology of Species-Specific Immune Checkpoint InhibitorsSession Category: Immunology -Immune Checkpoints |
|
617 |
MEK Inhibitor Rescued the Efficacy of PD-1 Blocker in STK11/LKB1 Mutated Colorectal Cancer ModelSession Category: Immunology -Immune Response to Therapies 2 / Immune Monitoring and Clinical Correlates |
1660 |
Comparison Between Surgical and Ultrasound-Guided Orthotopic Implantation of Hepatocellular Carcinoma Models in Mice Using Ultrasound and Bioluminescence ImagingSession Category: Tumor Biology - Humanized Mouse Models, Imaging, and Immuno-Oncology |
|
2059 |
Immunotherapy Testing in 3D Ex Vivo Patient Tissue Platform with Preserved Tumor MicroenvironmentSession Category: Immunology -Immune Response to Therapies 1 |
2743 |
Tumor Growth Modeling and its Applications in Preclinical Pharmacology Studies to Improve Translatability of Animal ModelsSession Category: Bioinformatics / Convergence Science / Systems Biology - Mathematical Models |
|
3110 |
Identification of the Phosphorylation Network in PDX and Corresponding Organoid (PDXO) Models Upon Targeted Therapy Treatment Using Deep Phosphoproteomic AnalysisSession Category: Tumor Biology - Patient-Derived Xenografts |
|
3115 |
Establishment and Characterization of Patient-Derived Breast Cancer Models for Cancer StudiesSession Category: Tumor Biology - Patient-Derived Xenografts |
|
3371 |
Impact of RNA Degradation on Transcriptomic Profiling in Tumor Samples from Syngeneic Mouse ModelsSession Category: Bioinformatics / Convergence Science / Systems Biology - Application of Bioinformatics to Cancer Biology 2 |
|
3541 |
A Method to Visualize and Quantify Effects of Immunotherapies in a Physiologically Relevant 3D TME ModelSession Category: Immunology -Modifiers of the Tumor Microenvironment |
4221 |
Characterization of OVA-Expressing Immunogenic Syngeneic Tumor Models for Immune Checkpoint Inhibitor EvaluationSession Category: Immunology -Immunomodulatory Agents and Interventions 3 |
|
4240 |
In Vivo Assessment of AICD and Cytokine Release Upon Treatment of OKT3 and CD3 Bispecific Antibody in Homozygous CD3EDG HuGEMM™Session Category: Immunology -Immunomodulatory Agents and Interventions 3 |
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-05-22
2022-03-15
landing_page